OpGen

OpGen Net Margin

The Net Profit Margin of OpGen (OPGN) as of Oct 19, 2026 is 78.21 %. In the previous year, Net Profit Margin was 230.80 % — a change of -66.11% (lower).

Net Margin

78.21 %

YoY

-66.11%

Last updated:

Net Profit Margin of OpGen is 2025 78.21 % . Net Profit Margin of OpGen was 2024 230.80 % . It decreases by -66.11% lower compared to the previous year.

OpGen's net margin stands at 78.2%, up from -808.3% several years earlier.

The OpGen Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-453.77 USD
Jan 1, 2019
-355.70 USD
Jan 1, 2020
-622.00 USD
Jan 1, 2021
-808.31 USD
Jan 1, 2022
-1,430.11 USD
Jan 1, 2023
-955.79 USD
Jan 1, 2024
230.80 USD
Jan 1, 2025
78.21 USD
The OpGen Net Margin history
YEARNet MarginYoY
78.21 %-66.11%
230.80 %-124.15%
-955.79 %-33.17%
-1,430.11 %+76.93%
-808.31 %+29.95%
-622.00 %+74.87%
-355.70 %-21.61%
-453.77 %-5.34%
-479.38 %+0.69%
-476.11 %-13.35%
-549.46 %+299.77%
-137.45 %+3,169.67%
-4.20 %+71.65%
-2.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Net Profit Margin of OpGen is 78.21 % in 2025.

Net Profit Margin of OpGen changed from 230.80 % to 78.21 %, representing a -66.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin OpGen since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's OpGen with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — OpGen

All Key Metrics — OpGen